Knight Therapeutics Inc. (TSX:GUD)

Knight Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	81.88	80.11	58.76	71.68	85.96	229.59
Short-Term Investments	20.96	92.73	96.61	87.1	63.54	147.32
Trading Asset Securities	15.3	-	14.5	26.83	10.65	29.15
Cash & Short-Term Investments	118.14	172.84	169.87	185.61	160.16	406.05
Cash Growth	-31.44%	1.75%	-8.48%	15.89%	-60.56%	-1.99%
Accounts Receivable	117.89	105.2	88.72	94.89	55.39	62.52
Other Receivables	12.25	8.34	9.51	13.68	12.03	19.53
Receivables	130.14	113.53	98.23	114	69.96	87.15
Inventory	144.4	102.7	91.83	92.49	72.4	56.51
Prepaid Expenses	8.02	7.74	4.88	3.34	2.17	2.21
Other Current Assets	-	-	0.3	0.18	0.29	0.18
Total Current Assets	400.7	396.81	365.12	395.62	304.97	552.1
Property, Plant & Equipment	21.78	20.02	17.86	22.63	29.94	26.16
Long-Term Investments	71.91	103.43	116.36	152.33	174.23	169.79
Goodwill	92.24	86.48	79.84	82.27	75.4	77.73
Other Intangible Assets	377.42	283.61	289.96	338.78	350.3	156.55
Long-Term Deferred Tax Assets	29.93	21.25	19.39	9.31	2.05	2.43
Other Long-Term Assets	54.61	52.2	53.3	50.13	51.28	51.18
Total Assets	1,049	963.8	945.49	1,055	991.89	1,040
Accounts Payable	112.85	78.35	85.37	106.06	65.31	44.51
Short-Term Debt	-	2.12	0.61	1.61	9.19	10.11
Current Portion of Long-Term Debt	17.81	15.37	17.24	16.06	17.48	41.66
Current Portion of Leases	3.74	2.64	1.73	2.58	1.61	1.88
Current Income Taxes Payable	0.48	0.21	1.18	2.27	7.07	13.56
Other Current Liabilities	17.81	12.56	7.9	12.73	4.64	2.34
Total Current Liabilities	152.68	111.25	114.03	141.32	105.3	114.06
Long-Term Debt	78.74	25.9	44.02	52.4	9.27	-
Long-Term Leases	5.96	3.43	5.5	5.05	3.42	2.54
Long-Term Deferred Tax Liabilities	2.85	3.84	2.82	4.37	12.37	21.62
Other Long-Term Liabilities	41.56	24.27	32.26	25.85	19.52	15.22
Total Liabilities	281.78	168.69	198.62	228.98	149.87	153.44
Common Stock	532.79	534.27	540.05	599.06	628.85	694.35
Additional Paid-In Capital	29.52	25.71	25.99	23.66	21.78	18.73
Retained Earnings	140.42	154.79	150.89	161.76	191.65	174.55
Comprehensive Income & Other	64.06	80.34	29.95	41.38	-0.26	-1.39
Total Common Equity	766.79	795.11	746.87	825.86	842.02	886.24
Shareholders' Equity	766.79	795.11	746.87	825.86	842.02	886.24
Total Liabilities & Equity	1,049	963.8	945.49	1,055	991.89	1,040
Total Debt	106.24	49.46	69.09	77.7	40.96	56.19
Net Cash (Debt)	11.9	123.38	108.18	123.08	119.2	365.18
Net Cash Growth	-89.91%	14.04%	-12.10%	3.26%	-67.36%	-23.76%
Net Cash Per Share	0.12	1.22	1.01	1.07	0.96	2.77
Filing Date Shares Outstanding	99.29	100.05	101.17	110.13	117.03	128.76
Total Common Shares Outstanding	99.68	100.05	101.17	112.21	117.78	130.04
Working Capital	248.02	285.57	251.09	254.3	199.67	438.04
Book Value Per Share	7.69	7.95	7.38	7.36	7.15	6.82
Tangible Book Value	297.14	425.02	377.07	404.8	416.32	651.97
Tangible Book Value Per Share	2.98	4.25	3.73	3.61	3.53	5.01
Land	-	0.01	0.93	1.55	1.09	0.89
Buildings	-	18.5	9.84	14.56	7.69	6.3
Machinery	-	42.56	21.91	33.13	25.94	18.16

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.